Form 4: Director Keith Acquires TMO Phantom Stock Units

Thermo Fisher Scientific Director R. Alexandra Keith acquired 66.02 phantom stock units valued at $473.36 each under the company's deferred compensation plan.

Summary

• R. Alexandra Keith, a Director of Thermo Fisher Scientific Inc. (TMO), acquired 66.02 phantom stock units.
• The acquisition occurred on March 28, 2026, at a price of $473.36 per unit.
• These units were credited to her account under the Issuer's Deferred Compensation Plan for Directors.
• Directors' retainers are deferred quarterly as Common Stock units based on the closing price of the stock as of the quarter end.
• The phantom stock units are convertible into Common Stock on a 1-for-1 basis.
• Shares are distributable upon cessation of director service or a change of control.
• Following this transaction, R. Alexandra Keith beneficially owns 1,270.44 phantom stock units.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting a routine director compensation transaction that increases insider ownership and aligns director interests with long-term company performance.

Positives

• Director R. Alexandra Keith increased her beneficial ownership in Thermo Fisher Scientific Inc. by acquiring 66.02 phantom stock units, aligning her interests with shareholders.
• The acquisition is part of a deferred compensation plan, indicating a structured approach to director remuneration and long-term commitment.

Future Outlook

The phantom stock units are distributable as common stock upon cessation of director service or a change of control, indicating a future conversion event tied to specific conditions.

Industry Context

StockSavvy.ai notes that deferred compensation plans for directors, often involving equity-based units, are a common practice across various industries, including the life sciences and diagnostics sector where Thermo Fisher Scientific operates. These plans aim to align director interests with long-term shareholder value and retain experienced board members.

Comparison to Industry Standards

• StockSavvy.ai observes that the use of phantom stock units as part of a director's deferred compensation plan is a standard practice in large-cap companies, particularly those in the S&P 500 like Thermo Fisher Scientific.
• Companies such as Johnson & Johnson (JNJ) and Danaher Corporation (DHR), which operate in related sectors, also utilize similar equity-based compensation structures for their non-employee directors to foster long-term commitment and align incentives with company performance.
• The 1-for-1 conversion to common stock upon specific events is a typical feature of such plans.

Corporate Governance

Related Party Transactions

• Acquisition of 66.02 phantom stock units by Director R. Alexandra Keith under the Issuer's Deferred Compensation Plan for Directors, where directors' retainers are deferred quarterly as Common Stock units.

Stakeholder Impact

• Shareholders: Increased alignment of director's interests with long-term shareholder value due to equity-based compensation.
• Directors: Provides a structured deferred compensation mechanism, encouraging long-term commitment to the company.

Next Steps

• The phantom stock units will convert to common stock upon R. Alexandra Keith's cessation of director service.
• The phantom stock units will convert to common stock upon a change of control of the company.

Key Dates

Recommendation

This Form 4 filing reports a routine acquisition of phantom stock units by a director as part of a deferred compensation plan. While it indicates continued insider alignment, it does not present new information that would fundamentally alter the investment thesis for Thermo Fisher Scientific. The transaction is expected and does not suggest any significant change in the company's operational or financial outlook, thus a 'hold' recommendation is appropriate for existing investors.

Keywords

Thermo Fisher Scientific, TMO, Form 4, Insider Transaction, Phantom Stock Units, Director Compensation, Deferred Compensation, Equity Acquisition